| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| NQO1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300620 | 10 ug | ORIGENE TECHNOLOGIES |
| NQO2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302889 | 10 ug | ORIGENE TECHNOLOGIES |
| Nqo1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN311189 | 1 kit | ORIGENE TECHNOLOGIES |
| Nqo1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN311189BN | 1 kit | ORIGENE TECHNOLOGIES |
| Nqo1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN311189LP | 1 kit | ORIGENE TECHNOLOGIES |
| Nqo1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN311189RB | 1 kit | ORIGENE TECHNOLOGIES |
| Nradd - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN511217 | 1 kit | ORIGENE TECHNOLOGIES |
| NR5A1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207577 | 1 kit | ORIGENE TECHNOLOGIES |
| NR5A1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207577BN | 1 kit | ORIGENE TECHNOLOGIES |
| NR5A1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207577LP | 1 kit | ORIGENE TECHNOLOGIES |
| NR5A1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207577RB | 1 kit | ORIGENE TECHNOLOGIES |
| NR5A2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN213887 | 1 kit | ORIGENE TECHNOLOGIES |
| Human exocyst complex component 8 (EXOC8) from ORIGENE TECHNOLOGIES | TP307859 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exocyst complex component 6 (EXOC6), transcript variant 1 from ORIGENE TECHNOLOGIES | TP306163 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exocyst complex component 7 (EXOC7), transcript variant 2 from ORIGENE TECHNOLOGIES | TP322329 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exocyst complex component 7 (EXOC7), transcript variant 6 from ORIGENE TECHNOLOGIES | TP327527 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exocyst complex component 4 (EXOC4), transcript variant 2, full length from ORIGENE TECHNOLOGIES | TP760869 | 50 ug | ORIGENE TECHNOLOGIES |
| Human exonuclease 3'-5' domain containing 3 (EXD3) from ORIGENE TECHNOLOGIES | TP322174 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exonuclease 3'-5' domain containing 1 (EXD1) from ORIGENE TECHNOLOGIES | TP306223 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exoribonuclease 1 (ERI1) from ORIGENE TECHNOLOGIES | TP306777 | 20 ug | ORIGENE TECHNOLOGIES |
| Human 5'-3' exoribonuclease 2 (XRN2) from ORIGENE TECHNOLOGIES | TP323980 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 1 (EXOSC1) from ORIGENE TECHNOLOGIES | TP306007 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 2 (EXOSC2) from ORIGENE TECHNOLOGIES | TP300753 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 8 (EXOSC8) from ORIGENE TECHNOLOGIES | TP304768 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 5 (EXOSC5) from ORIGENE TECHNOLOGIES | TP310665 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 3 (EXOSC3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP300035 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 7 (EXOSC7), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301419 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 9 (EXOSC9), transcript variant 1 from ORIGENE TECHNOLOGIES | TP323537 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 3 (EXOSC3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP318361 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exostoses (multiple)-like 1 (EXTL1) from ORIGENE TECHNOLOGIES | TP309064 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exostoses (multiple)-like 2 (EXTL2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP307406 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exportin 6 (XPO6) from ORIGENE TECHNOLOGIES | TP314839 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exportin 5 (XPO5) from ORIGENE TECHNOLOGIES | TP309420 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Extremities; Histiocytoma, malignant fibrous, metastatic from ORIGENE TECHNOLOGIES | CS607224 | 5x5um | ORIGENE TECHNOLOGIES |
| Human extracellular matrix protein 1 (ECM1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301118 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ezrin (EZR), transcript variant 1 from ORIGENE TECHNOLOGIES | TP300404 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ezrin (EZR), transcript variant 2 from ORIGENE TECHNOLOGIES | TP325989 | 20 ug | ORIGENE TECHNOLOGIES |
| SIAH3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423820 | 1 kit | ORIGENE TECHNOLOGIES |
| SIAH1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406576 | 1 kit | ORIGENE TECHNOLOGIES |
| Siah2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515772 | 1 kit | ORIGENE TECHNOLOGIES |
| SIAH2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303802 | 10 ug | ORIGENE TECHNOLOGIES |
| Siah3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515773 | 1 kit | ORIGENE TECHNOLOGIES |
| Sialic acid acetylesterase (SIAE) from ORIGENE TECHNOLOGIES | LY406912 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 1, sialoadhesin (SIGLEC1) from ORIGENE TECHNOLOGIES | LY411501 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 14 (SIGLEC14) from ORIGENE TECHNOLOGIES | LY420640 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 15 (SIGLEC15) from ORIGENE TECHNOLOGIES | LY403725 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 5 (SIGLEC5) from ORIGENE TECHNOLOGIES | LY418402 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 8 (SIGLEC8) from ORIGENE TECHNOLOGIES | LY415267 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 9 (SIGLEC9) from ORIGENE TECHNOLOGIES | LY402335 | 100 ug | ORIGENE TECHNOLOGIES |
| Sialic acid binding Ig-like lectin 10 (SIGLEC10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409681 | 100 ug | ORIGENE TECHNOLOGIES |